Stay updated on Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0. This appears to be a backend/versioning update and does not change study content.
    Difference
    0.1%
    Check dated 2025-11-24T17:54:51.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    - Removed a site-wide notice about a lapse in government funding and NIH operating status. The study record details (title, conditions, interventions, outcomes) remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T17:51:57.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    No additions or deletions were detected between the two screenshots, and the Study Details page content and layout appear unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T12:29:17.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Major update: version bumped to v3.2.0 with a prominent notice about funding-related access limits and where to check current operating status; previously listed v3.1.0 has been removed.
    Difference
    2%
    Check dated 2025-10-05T17:20:46.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T10:09:30.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. Removed the 'Back to Top' link.
    Difference
    0.1%
    Check dated 2025-09-14T00:16:09.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.